<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1084</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>14962380</PubmedId>
            <Abstract>447-52D is a human monoclonal antibody isolated from a heterohybridoma derived from an HIV-1-infected individual. This antibody recognizes the hypervariable gp120 V3 loop, and neutralizes both X4 and R5 primary isolates, making it one of the most effective anti-V3 antibodies characterized to date. The crystal structure of the 447-52D Fab in complex with a 16-mer V3 peptide at 2.5 A resolution reveals that the peptide beta hairpin forms a three-stranded mixed beta sheet with complementarity determining region (CDR) H3, with most of the V3 side chains exposed to solvent. Sequence specificity is conferred through interaction of the type-II turn (residues GPGR) at the apex of the V3 hairpin with the base of CDR H3. This novel mode of peptide-antibody recognition enables the antibody to bind to many different V3 sequences where only the GPxR core epitope is absolutely required.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>193-204</ArticlePages>
            <ArticleTitle>Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Stanfield</LastName>
                    <ForeName>Robyn L</ForeName>
                </Author>
                <Author>
                    <LastName>Gorny</LastName>
                    <ForeName>Miroslaw K</ForeName>
                </Author>
                <Author>
                    <LastName>Williams</LastName>
                    <ForeName>Constance</ForeName>
                </Author>
                <Author>
                    <LastName>Zolla-Pazner</LastName>
                    <ForeName>Susan</ForeName>
                </Author>
                <Author>
                    <LastName>Wilson</LastName>
                    <ForeName>Ian A</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.</Affiliations>
            <ArticleChemicalList>HIV Envelope Protein gp120;Immunoglobulin Fab Fragments</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Motifs; Crystallography; HIV Envelope Protein gp120(chemistry; immunology); HIV-1(chemistry; immunology); Immunoglobulin Fab Fragments(chemistry); Magnetic Resonance Spectroscopy; Models, Molecular; Neutralization Tests</ArticleMeshHeadingsList>
            <Comments>14962377  Structure (Camb). 2004 Feb;12(2):173-4</Comments>
            <Journal>
                <Volume>12</Volume>
                <Issue>2</Issue>
                <Title>Structure (London, England)</Title>
                <Issn>0969-2126</Issn>
                <MedlineTa>Structure</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>HIV envelope glycoprotein (304-309, 312-322)</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KRIHIGPGRAFYTT</LinearSequence>
                        <StartingPosition>310</StartingPosition>
                        <EndingPosition>323</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P05877.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11696</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Experimental procedures</LocationOfData>
                <EpitopeId>149350</EpitopeId>
                <ReferenceStartingPosition>305</ReferenceStartingPosition>
                <ReferenceEndingPosition>321</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Exact match to reference information</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figures 1, 4, 5, 6, 7, 8 and 9, Table 1, PDB 1Q1J</LocationOfData>
                        <BCellId>1842035</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:526</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Human mAb(s) were produced as previously described by Gorny et al. (1989) Proc Natl Acad Sci USA 86:1624 [PMID: 2922401]. The parent mAb 447-52D was isolated from a clade B HIV-1 infected individual.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.5</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>Structure of the interaction between Fab 447-52D and the epitope was determined by X-ray crystallography. The peptide was synthesized to contain a cysteine residue at its N- and C-termini. The HXB2 reference numbering of the epitope residues is: K305, R306, I307, H308, I309, G312, P313, G314, R315, A316, F317, Y318, T319, T320.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>Fab 447-52D</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG3</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Lambda</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>Fab 447-52D</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1Q1J_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1Q1J_L</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Peptide MP1</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KRIHIGPGRAFYTT</LinearSequence>
                                        <StartingPosition>310</StartingPosition>
                                        <EndingPosition>323</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P05877.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11696</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1Q1J</ComplexPdbId>
                            <AntibodyChain1PdbChain>H</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>L</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>P</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <CuratedContacts>
                                <EpitopeResidues>P: K305, R306, I307, H308, I309, G312, P313, G314, R315, A316</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: ; L: ;</AntibodyResiduesInteractingWithAntigen>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>P: K305, R306, I307, H308, I309, G312, P313, G314, R315</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: W33, R50, K52, D95, Y100J, Y100I, E100E, D100F, Y100H, Y100G; L: Y32, W91, A95B, W96</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>686.4</ContactAreaForAntigen>
                                <ContactAreaForAntibody>548.0</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

